Evaluation of interference from 16 hemoglobin variants on hemoglobin A


Journal

Scandinavian journal of clinical and laboratory investigation
ISSN: 1502-7686
Titre abrégé: Scand J Clin Lab Invest
Pays: England
ID NLM: 0404375

Informations de publication

Date de publication:
02 2023
Historique:
pubmed: 20 12 2022
medline: 14 2 2023
entrez: 19 12 2022
Statut: ppublish

Résumé

Hb variants prevalent in China are different from those in other countries. We aimed to assess the interference from Hb variants found in China on HbA1c measurement. All Hb variants were confirmed using Sanger sequencing. HbA1c was measured using a capillary electrophoresis method (Capillarys 3 OCTA), two cation-exchange high-performance liquid chromatography methods (ADAMS HA-8180V and HLC-723 G8 standard mode), an immunoassay (Cobas c501), and a boronate affinity chromatography method (Premier Hb9210). Premier Hb9210 was used as a comparative method. A total of 16 species of Hb variants were identified in 102 variant carriers. The most common variant was Hb E, followed by Hb Q-Thailand, Hb New York and Hb J-Bangkok. Clinically significant interference was observed for the Capillarys 3 OCTA (two Hb variants), ADAMS HA-8180V (seven Hb variants), HLC-723 G8 (14 Hb variants), and Cobas c501 (two Hb variants). The proportion of unacceptable HbA1c results was 13.7% for Capillarys 3 OCTA, 52.9% for HA-8180V, 83.3% for HLC-723 G8, and 3.9% for Cobas c501. Hb variants in China severely affect the accuracy of some commonly used HbA1c methods.

Identifiants

pubmed: 36534489
doi: 10.1080/00365513.2022.2155990
doi:

Substances chimiques

Glycated Hemoglobin 0
hemoglobin AS 52012-19-8
Hemoglobins, Abnormal 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

18-22

Auteurs

Xiaoling Yang (X)

Department of Laboratory Medicine, Shenzhen Baoan District Songgang People's Hospital, Shenzhen, China.

Xianwei Zeng (X)

Department of Laboratory Medicine, Shenzhen Baoan District Songgang People's Hospital, Shenzhen, China.

Yonggang Zhang (Y)

Department of Laboratory Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China.

Wenbin Kuang (W)

Department of Laboratory Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China.

Dabao He (D)

Department of Laboratory Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH